Anika Therapeutics, Inc. Renews Shareholder Rights Plan.BEDFORD, Mass. -- Anika Therapeutics, Inc. (NASDAQ NASDAQ in full National Association of Securities Dealers Automated Quotations U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on : ANIK ANIK Canadian COMSAT ) announced today that its Board of Directors has renewed its Shareholder Rights Plan. The renewed plan is similar to the original plan that had been in existence for 10 years and is due to expire soon. Shareholder rights plans are designed to strengthen the ability of a board of directors to protect a company's stockholders against abusive or coercive takeover tactics that are not in the best interests of the company and its stockholders. Details of the plan can be found in Anika's Form 8-K Form 8-K The form required by the SEC when a publicly held company incurs any event that might affect its financial situation or the share value of its stock. Form 8-K See 8-K. , which will be filed shortly with the Securities and Exchange Commission. About Anika Therapeutics, Inc. Headquartered in Bedford, Mass., Anika Therapeutics, Inc. develops, manufactures and commercializes therapeutic products for tissue protection, healing and repair. These products are based on hyaluronic acid (HA), a naturally occurring, biocompatible biocompatible /bio·com·pat·i·ble/ (-kom-pat´i-b'l) being harmonious with life; not having toxic or injurious effects on biological function. polymer found throughout the body. Anika's products include ORTHOVISC([R]), a treatment for osteoarthritis osteoarthritis or osteoarthrosis or degenerative joint disease Most common joint disorder, afflicting over 80% of those who reach age 70. It does not involve excessive inflammation and may have no symptoms, especially at first. of the knee available internationally and marketed in the U.S. by DePuy Mitek; HYVISC([R]), a treatment for equine osteoarthritis marketed in the U.S. by Boehringer Ingelheim Vetmedica, Inc.; the ELEVESS([TM]) family of aesthetic dermatology products for facial wrinkles, scar remediation and lip augmentation; AMVISC([R]), AMVISC([R]) Plus, STAARVISC[TM]-II and Shellgel[TM] injectable viscoelastic Adj. 1. viscoelastic - having viscous as well as elastic properties natural philosophy, physics - the science of matter and energy and their interactions; "his favorite subject was physics" HA products for ophthalmic surgery; INCERT([R]), an HA-based anti-adhesive for surgical applications; ORTHOVISC([R])Mini a treatment for osteoarthritis targeting small joints and available in Europe, MONOVISC([TM])a single-injection osteoarthritis product based on our proprietary cross-linking technology and scheduled to launch in Europe mid year 2008,and next generation products for joint health and aesthetic dermatology based on the Company's proprietary, chemically modified HA. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion